Редактирование:
SMS
Перейти к навигации
Перейти к поиску
Внимание:
Вы не вошли в систему. Ваш IP-адрес будет общедоступен, если вы запишете какие-либо изменения. Если вы
войдёте
или
создадите учётную запись
, её имя будет использоваться вместо IP-адреса, наряду с другими преимуществами.
Анти-спам проверка.
Не
заполняйте это!
Spermine synthase (EC 2.5.1.22) (SPMSY) (Spermidine aminopropyltransferase) ==Publications== {{medline-entry |title=Does a Live Performance Impact Synchronization to Musical Rhythm in Cognitively Impaired Elderly? |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/33104027 |abstract=Music-based interventions appear to be efficient approaches to improve emotional, social, and cognitive functioning of patients with neurodegenerative diseases. Because benefits seem to increase with patient's motor involvement, we studied sensorimotor synchronization ([[SMS]]) abilities of patients with cognitive impairments (Alzheimer's disease, vascular and mixed dementia) and of patients with no evidence of cognitive impairments. More specifically, we compared the impact of a live performance by a musician to a video recording on [[SMS]]. [[SMS]] to a metronomic or a musical stimulus was assessed while patients watched a live musician or his pre-recorded video. [[SMS]] to a metronome was better than to music but this effect was modulated by the social context. While [[SMS]] to a metronome was better when facing a video than a live performance, there was no impact of social context on [[SMS]] to music. No group differences of [[SMS]] were found. The decrease in [[SMS]] to a metronome in a live performance may be due to social pressure. Such a pressure might be removed in pleasant social activities, like moving with music in a group, explaining the lack of effect on [[SMS]] to music. We found no performance differences in groups, suggesting relatively spared [[SMS]] in cognitively impaired patients. By showing that it is possible to encourage patients to synchronize with others, even when facing a video, our results indicate that [[SMS]] can be used as a relevant predictor in clinical trials and open up promising therapeutic options for isolated patients. |keywords=* Aging * Alzheimer’s disease * cognitive impairment * dementia * motor activity * music therapy * social interaction |full-text-url=https://sci-hub.do/10.3233/JAD-200521 }} {{medline-entry |title=Testing the effectiveness of physical activity advice delivered via text messaging vs. human phone advisors in a Latino population: The On The Move randomized controlled trial design and methods. |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/32659437 |abstract=Physical inactivity is a key risk factor for a range of chronic diseases and conditions, yet, approximately 50% of U.S. adults fall below recommended levels of regular aerobic physical activity (PA). This is particularly true for ethnic minority populations such as Latino adults for whom few culturally adapted programs have been developed and tested. Text messaging ([[SMS]]) represents a convenient and accessible communication channel for delivering targeted PA information and support, but has not been rigorously evaluated against standard telehealth advising programs. The objective of the On The Move randomized controlled trial is to test the effectiveness of a linguistically and culturally targeted [[SMS]] PA intervention ([[SMS]] PA Advisor) versus two comparison conditions: a) a standard, staff-delivered phone PA intervention (Telephone PA Advisor) and b) an attention-control arm consisting of a culturally targeted [[SMS]] intervention to promote a healthy diet ([[SMS]] Nutrition Advisor). The study sample (N = 350) consists of generally healthy, insufficiently active Latino adults ages 35 years and older living in five northern California counties. Study assessments occur at baseline, 6, and 12 months, with a subset of participants completing 18-month assessments. The primary outcome is 12-month change in walking, and secondary outcomes include other forms of PA, assessed via validated self-report measures and supported by accelerometry, and physical function and well-being variables. Potential mediators and moderators of intervention success will be explored to better determine which subgroups do best with which type of intervention. Here we present the study design and methods, including recruitment strategies and yields. Trial Registration: clinicaltrial.gov Identifier = NCT02385591. |keywords=* Aging * Digital health * Latino * Physical activity * Text-messaging * mHealth |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351675 }} {{medline-entry |title=Mobile Health Interventions for Physical Activity, Sedentary Behavior, and Sleep in Adults Aged 50 Years and Older: A Systematic Literature Review. |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/30507266 |abstract=We provide a systematic review of interventions utilizing mobile technology to alter physical activity, sedentary behavior, and sleep among adults aged 50 years and older. A systematic search identified 52 relevant articles (randomized control trial [RCT], quasi-experimental, pre/post single-group design). Of 50 trials assessing physical activity, 17 out of 29 RCTs and 13 out of 21 trials assessed for pre/post changes only supported the effectiveness of mobile interventions to improve physical activity, and 9 studies (five out of 10 RCTs and all four pre/post studies) out of 14 reduced sedentary behavior. Only two of five interventions improved sleep (one out of two RCTs and one out of three pre/post studies). Text messaging was the most frequently used intervention (60% of all studies) but was usually used in combination with other components (79% of hybrid interventions included [[SMS]], plus either web or app components). Although more high-quality RCTs are needed, there is evidence supporting the effectiveness of mHealth approaches in those aged 50 years and older. |mesh-terms=* Aged * Exercise * Health Promotion * Humans * Middle Aged * Sedentary Behavior * Sleep * Telemedicine |keywords=* aging * behavior change * mHealth * smartphones * technologies |full-text-url=https://sci-hub.do/10.1123/japa.2017-0410 }} {{medline-entry |title=Senescence-messaging secretome factors trigger premature senescence in human endometrium-derived stem cells. |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/29397942 |abstract=Accumulating evidence suggests that the senescence-messaging secretome ([[SMS]]) factors released by senescent cells play a key role in cellular senescence and physiological aging. Phenomenon of the senescence induction in human endometrium-derived mesenchymal stem cells (MESCs) in response to [[SMS]] factors has not yet been described. In present study, we examine a hypothesis whether the conditioned medium from senescent cells (CM-old) may promote premature senescence of young MESCs. In this case, we assume that [[SMS]] factors, containing in CM-old are capable to trigger senescence mechanism in a paracrine manner. A long-term cultivation MESCs in the presence of CM-old caused deceleration of cell proliferation along with emerging senescence phenotype, including increase in both the cell size and SA-β-Gal activity. The phosphorylation of p53 and MAPKAPK-2, a direct target of p38MAPK, as well as the expression of p21Cip1 and p16Ink4a were increased in CM-old treated cells with senescence developing whereas the Rb phosphorylation was diminished. The senescence progression was accompanied by both enhanced ROS generation and persistent activation of DNA damage response, comprising protein kinase [[ATM]], histone H2A.X, and adapter protein 53BP1. Thus, we suggest that a senescence inducing signal is transmitted through p16/MAPKAPK-2/Rb and DDR-mediated p53/p21/Rb signaling pathways. This study is the first to demonstrate that the [[SMS]] factors secreted in conditioned medium of senescent MESCs trigger a paracrine mechanism of premature senescence in young cells. |mesh-terms=* Cell Communication * Cell Line * Cellular Senescence * Endometrium * Female * Humans * Mesenchymal Stem Cells * Proteome * Signal Transduction |keywords=* DNA damage response * Mesenchymal stem cells * SASP * Senescence propagation * Signaling pathway * Stress-induced senescence |full-text-url=https://sci-hub.do/10.1016/j.bbrc.2018.01.163 }} {{medline-entry |title=PAI-1-regulated extracellular proteolysis governs senescence and survival in Klotho mice. |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/24778222 |abstract=Cellular senescence restricts the proliferative capacity of cells and is accompanied by the production of several proteins, collectively termed the "senescence-messaging secretome" ([[SMS]]). As senescent cells accumulate in tissue, local effects of the [[SMS]] have been hypothesized to disrupt tissue regenerative capacity. Klotho functions as an aging-suppressor gene, and Klotho-deficient (kl/kl) mice exhibit an accelerated aging-like phenotype that includes a truncated lifespan, arteriosclerosis, and emphysema. Because plasminogen activator inhibitor-1 (PAI-1), a serine protease inhibitor (SERPIN), is elevated in kl/kl mice and is a critical determinant of replicative senescence in vitro, we hypothesized that a reduction in extracellular proteolytic activity contributes to the accelerated aging-like phenotype of kl/kl mice. Here we show that PAI-1 deficiency retards the development of senescence and protects organ structure and function while prolonging the lifespan of kl/kl mice. These findings indicate that a SERPIN-regulated cell-nonautonomous proteolytic cascade is a critical determinant of senescence in vivo. |mesh-terms=* Aging * Animals * Cellular Senescence * Cyclin-Dependent Kinase Inhibitor p16 * Extracellular Space * Female * Glucuronidase * Hemorrhagic Disorders * Longevity * Male * Mice * Mice, Inbred C3H * Mice, Inbred C57BL * Mice, Knockout * Phenotype * Plasminogen Activator Inhibitor 1 * Proteolysis * Serpin E2 * Telomere |keywords=* FGF23 * IGFBP3 * IL-6 * TM5441 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4024885 }}
Описание изменений:
Пожалуйста, учтите, что любой ваш вклад в проект «hpluswiki» может быть отредактирован или удалён другими участниками. Если вы не хотите, чтобы кто-либо изменял ваши тексты, не помещайте их сюда.
Вы также подтверждаете, что являетесь автором вносимых дополнений, или скопировали их из источника, допускающего свободное распространение и изменение своего содержимого (см.
Hpluswiki:Авторские права
).
НЕ РАЗМЕЩАЙТЕ БЕЗ РАЗРЕШЕНИЯ ОХРАНЯЕМЫЕ АВТОРСКИМ ПРАВОМ МАТЕРИАЛЫ!
Отменить
Справка по редактированию
(в новом окне)
Шаблон, используемый на этой странице:
Шаблон:Medline-entry
(
править
)
Навигация
Персональные инструменты
Вы не представились системе
Обсуждение
Вклад
Создать учётную запись
Войти
Пространства имён
Статья
Обсуждение
русский
Просмотры
Читать
Править
История
Ещё
Навигация
Начало
Свежие правки
Случайная страница
Инструменты
Ссылки сюда
Связанные правки
Служебные страницы
Сведения о странице
Дополнительно
Как редактировать
Вики-разметка
Telegram
Вконтакте
backup